On June 14, 2007, Mark Waxman presented at an AdvaMed MTLI Audio Conference on “CME Programs – Guidelines and Pitfalls for Sponsorship and Support.”
Topics discussed included the following:
- Why sponsor CME programs? What are the benefits to providers and to sponsors?
- What is the dividing line between education and promotion?
- What are the differences between formal CME programs and non-physician continuing education programs with manufacturer involvement?
- What are the risks of off-label promotion?
- What control does a sponsor have over CME program content?
- How does one draft the most equitable and productive Letter of Agreement between industry sponsors and CME providers?
- How can companies reduce their exposure to regulatory concerns?
Speakers:
- Sandy C. Kalter, Senior Legal Director and FDA Counsel, Corporate Legal/Regulatory, Medtronic, Inc.
- Sue Seferian, Senior Counsel, Johnson & Johnson
- Mark Waxman, Partner, Foley & Lardner LLP
Related Insights
21 March 2025
IP Litigation Current
Federal Circuit Opens the Door to Additional Domestic Industry Investment: “Ordinary Importer” No Longer
In its recent decision in Lashify, Inc. v. International Trade Commission, the Federal Circuit opened the door for patent owners to include expanded categories of domestic investment to satisfy the economic prong of the domestic industry requirement under Section 337(a)(3)(B).
21 March 2025
Manufacturing Industry Advisor
Federal Court Rejects FCA’s “65%-100%” Language as Insufficient to Constitute the Necessary Quantity Term in a Requirements Contract—A Win for Suppliers
A recent federal court decision marks an important win for automotive suppliers in the ongoing debate over what constitutes a valid requirements contract under Michigan law following the Michigan Supreme Court’s decision in MSSN, Inc. v. Airboss Flexible Products Co. (2023).
27 April 2025
Events
Innovative Payment Strategies in Proton Therapy: Addressing Challenges and Driving Value
Foley partner Kinal Patel is speaking at the 2025 National Proton Conference in a panel titled “Innovative Payment Strategies in Proton Therapy: Addressing Challenges and Driving Value” on April 27.